Page 6 - 《中国药房》2022年8期

Application of individualized rational drug use monitoring platform in promoting rational drug use of patients with
chronic diseases ………………………………… LUO Zhongping，ZHAO Jianglin，LI Zhenlin，CHEN Chen（1009）
Role of p38 MAPK signaling pathway on post-stroke cognitive impairment and pharmacological research progress
in the prevention and treatment with traditional Chinese medicine ……………………………………………
…………… DING Zhimin，GAO Jing，SU Kaiqi，YU Mingyue，QI Shikui，FENG Yixuan，FENG Xiaodong（1014）
Review on research and application of chloral hydrate preparations ………………………………………………
………………………………………………… LU Hua，HE Chengzhang，CHEN Zhenling，HUANG Renbin（1021）

CHINA PHARMACY （Semimonthly） Phone
Founded in January 1990 +86-23-63830521；+86-23-63830907；+86-23-68586727；
Vol.33，No.8，Apr. 2022 +86-23-68586827
Total No.722 Published on Apr. 30，2022 E-mail
info@china-pharmacy.com
Responsible Institution info@pharmacyvision.net
National Health Commission，P.R. China Website
Sponsored by http：//www.china-pharmacy.com
Chinese Hospital Association http：//www.pharmacyvision.net
Chongqing University Cancer Hospital Online Submission
Edited by http：//2018.china-pharmacy.com
China Pharmacy Editorial and Publishing Center http：//papers.pharmacyvision.net
Director of Editorial Commission Printed by
LI Linkang Chongqing Changhong Printing Co.，Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China：Chongqing Post Offices（Code No.78-33）
Editor-in-Chief Overseas：China International Book Trading Corporation
HU Xin （Code No.4703SM）
Vice Editor-in-Chief Subscription Rates
LENG Huaiming
Chief Editor CNY 15 per issue；CNY 360 per annum
ZHANG Jian CSSN ISSN 1001-0408
Published by CN 50-1055/R
China Pharmacy Editorial Department CODEN
Postal Address ZYHAA4
129 Daping Main Street，Yuzhong District，Chongqing Perennial Legal Counsel
400042，China Chongqing Huali Wantao Law Firm